Locations
Conditions
Treatments
Institutions
Resources
For researchers
About us
Clinical trials
Phase 3 Trial of Reltodecacog Alfa (VMX-C001) vs Usual Pharmacological Care in Patients Taking a FXa Direct Oral Anticoagulant Who Require Urgent Surgery With or Without Heparin.
Apply
VMX-C001
Phase 3 Trial of Reltodecacog Alfa (VMX-C001) vs Usual Pharmacological Care in Patients Taking a FXa Direct Oral Anticoagulant Who Require Urgent Surgery With or Without Heparin.
Basic information
Step 1/5
Provide your basic information
Age
ZIP code
Back
Next step